DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4szdk7/2014) has announced the addition of the "2014 Pharmaceutical & Healthcare Industry Trends" report to their offering.
With regards to the developed states, the biggest theme in the pharmaceutical sector in 2014 was consolidation and 'de-diversification', as increased competition and slower growth forced companies to plan for the long term. Furthermore, as governments focused on meeting debt reduction targets, the pharmaceutical industry remained a focus for cost containment in 2014.
With regards to emerging markets, while we saw expanding universal healthcare creating opportunities for drugmakers, the increased support of generic medicines and the growing enforcement of government containment initiatives also created challenging operating conditions in the high-growth markets.
The global pharmaceutical market is set to post a compound annual growth rate of 2.4% over the next five years. Combined sales of prescription drugs and over-the-counter medicines are forecast to increase from USD1,096bn in 2013 to USD1,114bn in 2014, representing year-on-year growth of 1.6%.
Due to the strong US dollar and weak currencies in emerging markets, the global pharmaceutical market will contract in 2015 - although it will expand in local currency terms.
Key Topics Covered:
1. Industry View
2. SWOT
3. Industry Forecasts
4. Macroeconomic Forecasts
5. Industry Risk Reward Index
6. Market Overview
7. Industry Trends & Developments
8. Regulatory Developments
9. Competitive Landscape
10. Methodology
For more information visit http://www.researchandmarkets.com/research/4szdk7/2014
